Form 8-K - Current report:
SEC Accession No. 0001564590-22-000853
Filing Date
2022-01-10
Accepted
2022-01-10 16:31:04
Documents
16
Period of Report
2022-01-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-8k_20220110.htm   iXBRL 8-K 46522
2 EX-10.1 eypt-ex101_8.htm EX-10.1 128273
3 EX-99.1 eypt-ex991_9.htm EX-99.1 16707
4 GRAPHIC gyqfqrkrrkrk000001.jpg GRAPHIC 5377
5 GRAPHIC gxexev5kvbsp000001.jpg GRAPHIC 17593
  Complete submission text file 0001564590-22-000853.txt   377998

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eypt-20220110.xsd EX-101.SCH 5701
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20220110_lab.xml EX-101.LAB 18676
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20220110_pre.xml EX-101.PRE 11137
10 EXTRACTED XBRL INSTANCE DOCUMENT eypt-8k_20220110_htm.xml XML 3417
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 22521617
SIC: 3826 Laboratory Analytical Instruments